This result didn't seem impressive to me. NPAT went from ~$5m in the 2nd half of '23 to ~$800k in 1H24. There isn't supposed to be seasonality in this business. Earnings aren't supposed to decline this much from half to half. The business clearly went backwards in the past 6 months or so.
Having said that, there's no point selling now. It looks like interest rates have peaked (ie. lower interest expense in coming years), and the positive revenue effect of the Dunlop deal yet to take effect. Earnings could conceivably be much higher several years down the track, along with market cap. Worth a speculative bet I think.
- Forums
- ASX - By Stock
- NTD
- Ann: Appendix 4D and Half-Year Financial Report
Ann: Appendix 4D and Half-Year Financial Report, page-15
-
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NTD (ASX) to my watchlist
|
|||||
Last
42.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $55.66M |
Open | High | Low | Value | Volume |
42.0¢ | 42.0¢ | 41.3¢ | $33.57K | 79.94K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 19795 | 41.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
42.0¢ | 15492 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 19795 | 0.415 |
2 | 52748 | 0.400 |
2 | 30349 | 0.385 |
2 | 58790 | 0.380 |
2 | 29732 | 0.370 |
Price($) | Vol. | No. |
---|---|---|
0.420 | 15492 | 2 |
0.430 | 40409 | 2 |
0.450 | 15000 | 1 |
0.455 | 45210 | 1 |
0.460 | 16000 | 1 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
NTD (ASX) Chart |